Proteomic Analysis of Alzheimer's Disease Cerebrospinal Fluid from Neuropathologically Diagnosed Subjects

By  

Current Alzheimer Research, Vol. 6, Iss. 4, 2009-08 ,pp. : 399-406

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

By Castaño Eduardo M.   Roher Alex E.   Esh Chera L.   Kokjohn Tyler A.   Beach Thomas  

Neurological Research, Vol. 28, Iss. 2, 2006-03 ,pp. : 155-163

Maney Publishing

Access to resources Recommend Favorite

DJ-1 and -synuclein in human cerebrospinal fluid as biomarkers of Parkinsons disease

By Hong Zhen  

Brain, Vol. 133, Iss. 3, 2010-03 ,pp. : 713-726

Oxford University Press

Access to resources Recommend Favorite

Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s disease

By Forte G.   Bocca B.   Senofonte O.   Petrucci F.   Brusa L.   Stanzione P.   Zannino S.   Violante N.   Alimonti A.   Sancesario G.  

Journal of Neural Transmission, Vol. 111, Iss. 8, 2004-08 ,pp. : 1031-1040

Springer Publishing Company

Access to resources Recommend Favorite

Parkinson’’s disease: diagnostic relevance of elevated levels of soluble αα-synuclein oligomers in cerebrospinal fluid

By Mukaetova-Ladinska Elizabeta B  

Future Neurology, Vol. 6, Iss. 2, 2011-03 ,pp. : 159-163

Future Medicine

Access to resources Recommend Favorite